Literature DB >> 21933980

Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.

W M Harriss-Phillips1, E Bezak, E K Yeoh.   

Abstract

OBJECTIVE: A temporal Monte Carlo tumour growth and radiotherapy effect model (HYP-RT) simulating hypoxia in head and neck cancer has been developed and used to analyse parameters influencing cell kill during conventionally fractionated radiotherapy. The model was designed to simulate individual cell division up to 10(8) cells, while incorporating radiobiological effects, including accelerated repopulation and reoxygenation during treatment.
METHOD: Reoxygenation of hypoxic tumours has been modelled using randomised increments of oxygen to tumour cells after each treatment fraction. The process of accelerated repopulation has been modelled by increasing the symmetrical stem cell division probability. Both phenomena were onset immediately or after a number of weeks of simulated treatment.
RESULTS: The extra dose required to control (total cell kill) hypoxic vs oxic tumours was 15-25% (8-20 Gy for 5 × 2 Gy per week) depending on the timing of accelerated repopulation onset. Reoxygenation of hypoxic tumours resulted in resensitisation and reduction in total dose required by approximately 10%, depending on the time of onset. When modelled simultaneously, accelerated repopulation and reoxygenation affected cell kill in hypoxic tumours in a similar manner to when the phenomena were modelled individually; however, the degree was altered, with non-additive results. Simulation results were in good agreement with standard linear quadratic theory; however, differed for more complex comparisons where hypoxia, reoxygenation as well as accelerated repopulation effects were considered.
CONCLUSION: Simulations have quantitatively confirmed the need for patient individualisation in radiotherapy for hypoxic head and neck tumours, and have shown the benefits of modelling complex and dynamic processes using Monte Carlo methods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933980      PMCID: PMC3473773          DOI: 10.1259/bjr/25012212

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  71 in total

1.  Mathematical models of repopulation and reoxygenation in radiotherapy.

Authors:  O C Scott
Journal:  Br J Radiol       Date:  1990-10       Impact factor: 3.039

2.  Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.

Authors:  Aste Søvik; Eirik Malinen; Øyvind S Bruland; Søren M Bentzen; Dag Rune Olsen
Journal:  Phys Med Biol       Date:  2006-12-29       Impact factor: 3.609

3.  Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions.

Authors:  W Dörr
Journal:  Int J Radiat Biol       Date:  1997-12       Impact factor: 2.694

4.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

5.  CELLSIM and CELLGROW: tools for cell kinetic modeling.

Authors:  C E Donaghey
Journal:  ISA Trans       Date:  1983       Impact factor: 5.468

6.  Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial.

Authors:  Jean Bourhis; Michel Lapeyre; Jacques Tortochaux; Michel Rives; Mehdi Aghili; Sylvain Bourdin; François Lesaunier; Toufik Benassi; Claire Lemanski; Lionel Geoffrois; Antoine Lusinchi; Pierre Verrelle; Etienne Bardet; Morbize Julieron; Pierre Wibault; Monique Luboinski; Ellen Benhamou
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

Review 7.  Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.

Authors:  J Overgaard; J Alsner; J Eriksen; M R Horsman; C Grau
Journal:  Rays       Date:  2000 Jul-Sep

8.  Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.

Authors:  Chris H J Terhaard; Henk B Kal; Gerrit-Jan Hordijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-05-01       Impact factor: 7.038

9.  Computer simulation of cytotoxic and vascular effects of radiosurgery in solid and necrotic brain metastases.

Authors:  M Kocher; H Treuer; J Voges; M Hoevels; V Sturm; R P Müller
Journal:  Radiother Oncol       Date:  2000-02       Impact factor: 6.280

10.  Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.

Authors:  A C Begg; I Hofland; J Kummermehr
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

View more
  10 in total

1.  Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer.

Authors:  L G Marcu; E Bezak
Journal:  Cell Prolif       Date:  2012-07-07       Impact factor: 6.831

2.  Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy.

Authors:  L G Marcu
Journal:  Cell Prolif       Date:  2014-05-13       Impact factor: 6.831

3.  Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen.

Authors:  Raj Patel; Quezia Lacerda; Brian E Oeffinger; John R Eisenbrey; Ankit K Rochani; Gagan Kaushal; Corinne E Wessner; Margaret A Wheatley
Journal:  Polymers (Basel)       Date:  2022-04-12       Impact factor: 4.967

4.  Altered fractionation outcomes for hypoxic head and neck cancer using the HYP-RT Monte Carlo model.

Authors:  W M Harriss-Phillips; E Bezak; E K Yeoh
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

5.  The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.

Authors:  W M Harriss-Phillips; E Bezak; E Yeoh
Journal:  Comput Math Methods Med       Date:  2012-06-19       Impact factor: 2.238

6.  Compensability index for compensation radiotherapy after treatment interruptions.

Authors:  Paul Martin Putora; Michael Schmuecking; Daniel Aebersold; Ludwig Plasswilm
Journal:  Radiat Oncol       Date:  2012-12-08       Impact factor: 3.481

Review 7.  In silico modelling of treatment-induced tumour cell kill: developments and advances.

Authors:  Loredana G Marcu; Wendy M Harriss-Phillips
Journal:  Comput Math Methods Med       Date:  2012-07-12       Impact factor: 2.238

8.  Simulation of head and neck cancer oxygenation and doubling time in a 4D cellular model with angiogenesis.

Authors:  Jake C Forster; Michael J J Douglass; Wendy M Harriss-Phillips; Eva Bezak
Journal:  Sci Rep       Date:  2017-09-08       Impact factor: 4.379

9.  Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.

Authors:  Christiane Matuschek; Jan Haussmann; Edwin Bölke; Stephan Gripp; Patrick J Schuler; Bálint Tamaskovics; Peter Arne Gerber; Freddy-Joel Djiepmo-Njanang; Kai Kammers; Christian Plettenberg; Bahar Anooshahr; Klaus Orth; Wilfried Budach
Journal:  Radiat Oncol       Date:  2018-10-04       Impact factor: 3.481

10.  Studying the regression profiles of cervical tumours during radiotherapy treatment using a patient-specific multiscale model.

Authors:  Christos A Kyroudis; Dimitra D Dionysiou; Eleni A Kolokotroni; Georgios S Stamatakos
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.